Financial Performance - For the six months ended September 30, 2021, the Global X MSCI China ETF reported a net loss of HK$150,413,971, compared to a profit of HK$225,654,532 in the same period of the previous year[7]. - The Global X CSI 300 ETF experienced a net loss of HK$3,485,394 for the six months ended September 30, 2021, compared to a profit of HK$2,080,241 in the prior year[7]. - The Global X China Cloud Computing ETF reported a net loss of HK$332,324,137 for the six months ended September 30, 2021[7]. - The Global X Hang Seng High Dividend Yield ETF reported a loss before tax of HK$3,485,404 for the six months ended 30 September 2021, compared to a profit of HK$2,080,241 in the same period of 2020[12]. - The total comprehensive income for the Global X MSCI China ETF was a loss of HK$150,413,971 for the period, contrasting with a profit of HK$225,654,532 in the previous year[8]. - Global X China Biotech ETF reported a loss before tax of RMB 91,204,697 for the six months ended 30 September 2021, compared to a profit of RMB 395,174,068 in the same period of 2020, indicating a significant decline in performance[16]. - Global X China Cloud Computing ETF experienced a loss before tax of RMB 332,223,227 for the same period, contrasting with a profit of RMB 246,444,305 in the prior year, reflecting a substantial downturn[18]. Asset and Liability Overview - As of September 30, 2021, total assets for the Global X MSCI China ETF amounted to HK$799,536,756, while the Global X Hang Seng High Dividend Yield ETF had total assets of HK$995,345,599[5]. - Total liabilities for the Global X China Cloud Computing ETF were RMB 26,513,639 as of September 30, 2021[5]. - The total net assets attributable to unitholders for the Global X China Biotech ETF were RMB 34,381,897 as of September 30, 2021[5]. - The total net assets attributable to unitholders at the end of the period for Global X MSCI China ETF were HK$799,124,560, a decrease from HK$995,159,184 at the beginning of the period, reflecting a decline of approximately 19.7%[8]. Cash Flow and Operations - The cash generated from operations for the Global X MSCI China ETF was HK$27,911,986, significantly lower than HK$230,898,259 in the previous year, indicating a decrease of approximately 87.9%[10]. - The net cash flows generated from operating activities for the Global X Hang Seng High Dividend Yield ETF were negative at HK$88,755,800, compared to positive cash flows of HK$14,031,697 in the previous year[12]. - Cash generated from operations for Global X China Biotech ETF was RMB 171,673,868, a recovery from a cash used in operations of RMB 716,020,496 in the previous year[16]. - Global X China Cloud Computing ETF reported cash used in operations of RMB 145,925,293, an improvement from RMB 720,654,827 in the previous year[18]. Management Fees and Expenses - The management fee for the Global X MSCI China ETF was HK$820,522 for the six months ended September 30, 2021[7]. - The management fee for the China Biotech ETF rose to RMB 6,457,134 in the period ended 30 September 2021, compared to RMB 3,574,594 in the previous year[95]. - The total management fee for the Hang Seng High Dividend Yield ETF was HK$144,013 for the period ended 30 September 2021, compared to HK$110,964 in the same period of 2020[95]. - The management fee for the Hang Seng High Dividend Yield ETF and China Biotech ETF was set at 0.68% effective October 1, 2021, while the China Cloud Computing ETF will adopt the same fee structure effective November 1, 2021[143]. Investment Holdings and Portfolio Composition - As of September 30, 2021, Alibaba Group Holding Ltd accounted for 10.29% of the MSCI China ETF's net asset value, while Tencent Holdings Ltd accounted for 12.66%[134]. - The MSCI China ETF holds a total fair value of HK$ 7,999,999,999 across various listed equities as of September 30, 2021[145]. - The investment strategy focuses on high-growth sectors, with a significant allocation to renewable energy and technology firms[146]. - The portfolio includes a diverse range of sectors, including technology, healthcare, and energy, with notable investments in companies like China National Chemical-A and China Shenhua Energy Co-A[146]. - The total fair value of financial assets at fair value through profit or loss is HK$120,074,313, representing 15.08% of net assets[153]. Changes in Holdings - The total closing holdings for the MSCI China ETF as of September 30, 2021, amounted to 923,017 million for China Petroleum & Chemical Corp, down from 1,000,546 million at the beginning of the period, reflecting a decrease of approximately 7.7%[175]. - The closing holdings for Want Want China Holdings Ltd decreased from 203,792 million to 183,177 million, representing a decline of approximately 10.2%[175]. - The total closing holdings for the energy sector, particularly for PetroChina Co Ltd-H, decreased from 878,648 million to 803,483 million, reflecting a decline of approximately 8.5%[175]. - The total closing holdings for the China Biotech ETF included 20,060,000 shares of Sino Biopharmaceutical, with a decrease of 4,731,000 shares from previous holdings[200]. Taxation and Regulatory Considerations - The Sub-Funds did not accrue any PRC Corporate Income Tax (CIT) and Value-Added Tax (VAT) provisions for gains made on China A-shares through RQFII quotas[128]. - The Sub-Funds were subject to a 10% PRC withholding income tax on dividend income received from China A-shares and H-shares[128]. Market Strategy and Economic Conditions - The ETF's performance is closely tied to the overall market trends in China, reflecting the economic conditions and regulatory environment[145]. - The overall market strategy appears focused on maintaining liquidity while selectively increasing positions in high-performing sectors such as energy and consumer staples[192].

Financial Assets and Net Asset Value - As of March 31, 2021, financial assets at fair value through profit or loss amounted to HK$986,710,267, representing 99.15% of the net asset value of Global X MSCI China ETF[14] - The net asset value of Global X Hang Seng High Dividend Yield ETF was HK$97,075,758, which represented 98.52% of its total net asset value[14] - Global X CSI 300 ETF reported financial assets at fair value of RMB43,666,287, accounting for 98.77% of its net asset value[14] - The net asset value of Global X China Biotech ETF was RMB2,486,647,149, representing 99.86% of its total net asset value[14] - Global X China Cloud Computing ETF had a net asset value of RMB1,076,567,695, which represented 99.65% of its total net asset value[14] - Certain equity investments in Global X MSCI China ETF and Global X CSI 300 ETF amounted to HK$1,326,254 and RMB183,485 respectively, representing 0.13% and 0.42% of their net asset values[14] Financial Performance - Total assets as of 31 March 2021 amounted to HK$ 995,345,599, an increase from HK$ 857,710,830 in 2020, representing a growth of approximately 16.1%[32] - Dividend income for the year ended 31 March 2021 was HK$ 15,604,371, a decrease of 45.5% compared to HK$ 28,782,293 in 2020[34] - The net gain on financial assets at fair value through profit or loss was HK$ 291,097,495, recovering from a loss of HK$ 133,428,316 in the previous year[34] - Operating profit for the year was HK$ 305,952,609, compared to an operating loss of HK$ 109,913,434 in 2020, indicating a significant turnaround[34] - Profit after tax for the year was HK$ 304,803,603, compared to a loss of HK$ 112,028,090 in the previous year, marking a substantial improvement[34] - The total comprehensive income for the year was HK$ 304,803,603, a significant recovery from the previous year's total comprehensive loss[34] Cash Flows and Unit Activity - Net cash flows generated from operating activities for Global X MSCI China ETF were HK$156,945,065, down from HK$803,305,893 in the previous year, reflecting a decrease of approximately 80%[37] - The number of units in issue for Global X MSCI China ETF decreased from 27,400,000 to 22,600,000, a reduction of about 17%[35] - Cash received from the issue of units for Global X Hang Seng High Dividend Yield ETF was HK$15,762,009, down from HK$27,726,043 in the previous year, a decline of approximately 43%[39] - The total cash and cash equivalents at the end of the year for Global X Hang Seng High Dividend Yield ETF increased to HK$2,027,195 from HK$597,316, representing a growth of approximately 238%[39] - Cash paid on redemptions of units for Global X CSI 300 ETF was RMB 82,361,757, significantly higher than RMB 6,436,146 in the previous year, reflecting increased redemption activity[41] Management Fees and Expenses - Management fees decreased to HK$ 571,054 from HK$ 599,491, reflecting a reduction of approximately 4.7%[34] - The management fee for the MSCI China ETF was HK$571,054, a decrease from HK$599,491 in 2020[126] - The China Biotech ETF management fee increased significantly to RMB9,166,612 in 2021 from RMB3,039,257 in 2020[126] - The annual management fee for China Biotech ETF is 0.13% for 2021, up from 0.10% in 2020[135] - The annual management fee for China Cloud Computing ETF is also 0.13% for 2021, an increase from 0.10% in 2020[135] Financial Liabilities and Equity - Total liabilities decreased to HK$ 186,415 from HK$ 14,602,196, indicating a significant reduction in obligations[32] - Net assets attributable to unitholders increased to HK$ 995,159,184 from HK$ 843,108,634, representing a growth of approximately 18%[32] - Redeemable units are classified as equity instruments if they meet specific criteria, including entitlement to a pro-rata share of net assets[88] - The Sub-Funds continuously assess the classification of redeemable units and may reclassify them as financial liabilities if they no longer meet the criteria[90] Investment Concentration and Sector Allocation - The investment in Alibaba Group Holding Limited represented 13.95% of the MSCI China ETF's net asset value as of March 31, 2021[177] - Tencent Holdings Ltd. accounted for 14.66% of the MSCI China ETF's net asset value as of March 31, 2021[177] - The MSCI China ETF's financial assets at fair value totaled HK$986,710,267, with a significant concentration in consumer discretionary (33.65%) and communication services (20.13%) sectors[182] - The China Biotech ETF's financial assets at fair value reached RMB 2,486,647,149, predominantly in the healthcare sector (99.86%) as of March 31, 2021[185] - The China Cloud Computing ETF had a total fair value of RMB 1,076,567,695, with a major focus on information technology (53.56%) as of March 31, 2021[185] Risk Analysis - Sensitivity analysis indicates that a 42.79% increase in the MSCI China ETF could raise net asset value by approximately HK$422,200,251, while a decrease would have a similar negative impact[187] - Currency risk analysis shows that a reasonable shift of 8.42% in RMB could impact the MSCI China ETF's net assets by HK$10,100,869 as of March 31, 2021[194] - The majority of the Sub-Funds' financial assets and liabilities are non-interest-bearing, indicating low exposure to interest rate risk[190] - The company is exposed to currency risk primarily from financial assets at fair value and bank balances denominated in currencies other than their respective functional currencies[192]

Financial Performance - As of September 30, 2020, the total assets for Global X MSCI China ETF were HK$837,589,431, a decrease from HK$857,710,830 as of March 31, 2020[5]. - The Global X China Biotech ETF reported a net asset value of RMB 39,851,196 as of September 30, 2020, compared to RMB 102,543,827 as of March 31, 2020, indicating a significant decline[5]. - For the six months ended September 30, 2020, the Global X MSCI China ETF generated a profit of HK$225,654,532, recovering from a loss of HK$118,812,708 in the same period of the previous year[7]. - Dividend income for the Global X MSCI China ETF was HK$14,964,575 for the six months ended September 30, 2020, down from HK$27,505,096 in the same period of 2019[7]. - The Global X Hang Seng High Dividend Yield ETF experienced a net loss of HK$19,861,794 for the six months ended September 30, 2020, compared to a profit in the previous year[7]. - The profit after tax for Global X MSCI China ETF was HK$225,654,532, compared to a loss of HK$118,812,708 in the same period last year, indicating a significant turnaround[9]. - The profit before tax for Global X CSI 300 ETF was RMB 19,795,472, compared to RMB 500,598 in the same period last year, indicating a substantial increase[16]. - Global X China Biotech ETF reported a profit before tax of RMB 395,174,068 for the six months ended 30 September 2020[18]. - Global X China Cloud Computing ETF reported a profit before tax of RMB 246,444,305 for the same period[20]. Asset Management - The Global X China Cloud Computing ETF's financial assets at fair value through profit or loss increased to RMB 1,423,379,522 as of September 30, 2020, up from RMB 450,725,283 as of March 31, 2020[6]. - The total equity for the Global X China Cloud Computing ETF was RMB 1,429,365,750 as of September 30, 2020, significantly higher than RMB 449,976,711 as of March 31, 2020[6]. - The total liabilities for the Global X China Cloud Computing ETF were RMB 12,012,430 as of September 30, 2020, compared to RMB 4,546,474 as of March 31, 2020, reflecting an increase in liabilities[6]. - The balance at the beginning of the period for Global X MSCI China ETF was HK$843,108,634, down from HK$1,755,770,208 in the previous year, representing a decrease of approximately 52%[9]. - The balance at the end of the period for Global X CSI 300 ETF was RMB 39,851,196, down from RMB 106,610,885 in the previous year, a decrease of about 63%[9]. - The total financial assets at fair value through profit or loss were held with Citibank, N.A., ensuring consistent management of financial assets[114]. Cash Flow and Financing Activities - The net cash flows generated from operating activities for Global X MSCI China ETF were HK$243,833,814, down from HK$581,361,916 in the previous year, reflecting a decrease of about 58%[12]. - The cash paid on redemption of units for Global X MSCI China ETF was HK$244,762,535, compared to HK$580,741,672 in the previous year, showing a reduction of approximately 58%[12]. - The net cash flows used in financing activities for Global X CSI 300 ETF were RMB 82,361,757, compared to RMB 6,436,147 in the previous year, reflecting a significant increase in cash outflows[16]. - Net cash flows generated from financing activities for Global X China Biotech ETF amounted to RMB 715,807,934, and for Global X China Cloud Computing ETF it was RMB 735,102,436[18][20]. Management Fees and Expenses - Management fees for the Global X MSCI China ETF decreased to HK$213,809 for the six months ended September 30, 2020, from HK$324,859 in the same period of the previous year[7]. - The management fee for the MSCI China ETF was 0.049% of the net asset value, while the China Biotech ETF had a management fee of 0.50%[95]. - The trustee fee for the MSCI China ETF for the six months ended 30 September 2020 was HK$218,173, compared to HK$330,783 for the same period in 2019[104]. - The total administration fee payable for MSCI China ETF as of 30 September 2020 was HK$58,646, down from HK$197,055 as of 31 March 2020[106]. - The total administration fee for China Biotech ETF for the six months ended 30 September 2020 was RMB 960,714, with RMB 542,655 attributed to other administration fees[110]. Investment Portfolio - The total fair value of holdings in the portfolio includes significant investments in companies like Sany Heavy Industry Co. with HK$577,020, making up 0.07% of net assets[146]. - The total fair value of the listed equities in the MSCI China ETF as of September 30, 2020, is HK$97,617,325[149]. - The total investments for the MSCI China ETF amounted to HK$820,931,911, representing 98.17% of net assets[155]. - The total cost of investments for the MSCI China ETF was HK$692,768,528[155]. - The total investments in the China Biotech ETF reached RMB 1,963,208,795, accounting for 99.57% of net assets[164]. - Total investments in the CSI 300 ETF amounted to RMB 39,692,774, representing 99.60% of net assets[162]. - The largest holding in the portfolio is Meituan Dianping-Class B, valued at RMB 158,375,318, accounting for 11.08% of net assets[166]. - The portfolio reflects a strategic focus on various sectors, including technology, pharmaceuticals, and finance[145]. Market and Regulatory Environment - The financial statements are prepared in accordance with International Financial Reporting Standards (IFRSs) and relevant disclosure provisions[31]. - The Trust has five sub-funds authorized by the Securities and Futures Commission of Hong Kong, including Global X China Biotech ETF and Global X China Cloud Computing ETF[23]. - No provision for Hong Kong profits tax has been made for the Sub-Funds, maintaining tax efficiency under the current regulations[126]. - The Sub-Funds did not accrue any PRC Corporate Income Tax (CIT) and Value-Added Tax (VAT) provisions for gains made on China A-shares through RQFII quotas, the Shanghai-Hong Kong Stock Connect, or the Shenzhen-Hong Kong Stock Connect[132]. - The Sub-Funds were subject to a 10% PRC Withholding Income Tax (WIT) on dividend income received from China A-shares and China H-shares[132]. Changes in Holdings - The total closing holdings for the Consumer Staples sector included significant positions such as Inner Mongolia Yili Industry Co. Ltd. with 14,572 million CNY, down from 51,672 million CNY at the beginning of the period, reflecting a disposal of 37,100 million CNY[193]. - The total closing holdings for the Financials sector included Ping An Bank at 24,372 million CNY, down from 78,072 million CNY, after a disposal of 53,700 million CNY[194]. - The total closing holdings for the Energy sector included PetroChina Co. Ltd. at 21,911 million CNY, down from 69,911 million CNY, after a significant disposal of 48,000 million CNY[193]. - The overall trend indicates a strategic reduction in holdings across various sectors, particularly in Consumer Staples and Financials[172][174].

Financial Position and Performance - The financial assets at fair value through profit or loss represented the majority of the net asset value of the Sub-Funds as of March 31, 2020[16]. - The financial statements provide a true and fair view of the financial position of the Sub-Funds as of March 31, 2020, in accordance with International Financial Reporting Standards (IFRSs)[11]. - The audit confirmed that the financial statements were free from material misstatement, whether due to fraud or error[25]. - Total assets for Global X MSCI China ETF as of March 31, 2020, amounted to HK$857,710,830, a decrease from HK$1,762,540,297 in 2019[34]. - The net loss for Global X MSCI China ETF for the year ended March 31, 2020, was HK$112,028,090, compared to a loss of HK$269,293,218 in the previous year[35]. - The total comprehensive income for Global X MSCI China ETF was a loss of HK$112,028,090, compared to a loss of HK$269,293,218 in the previous year, indicating an improvement in performance[36]. - The total equity attributable to unitholders for Global X MSCI China ETF was HK$843,108,634, down from HK$1,755,770,208 in 2019, reflecting a decrease of approximately 52.0%[34]. - The net cash flows generated from operating activities for Global X MSCI China ETF were HK$803,305,893, down from HK$1,905,245,674 in the previous year, indicating a decrease of about 58%[39]. - The cash received from the issue of units for Global X MSCI China ETF was HK$60,367,625, compared to HK$631,404,826 in the previous year, representing a decline of approximately 90%[39]. Financial Statements and Compliance - The Manager and Trustee are responsible for preparing financial statements that give a true and fair view in accordance with IFRSs[20]. - The financial statements include a statement of net assets, statement of profit or loss, and statement of cash flows for the relevant periods[10]. - The audit included procedures to address the risks of material misstatement of the financial statements[15]. - The financial statements were audited in accordance with International Standards on Auditing (ISAs)[12]. - The Manager and Trustee must ensure compliance with the relevant disclosure provisions of the trust deed and the SFC Code[22]. Investment Performance and Assets - Certain equity investments of Global X MSCI China ETF and Global X CSI 300 ETF amounted to HK$50,848 and RMB48,530 respectively, representing 0.01% and 0.05% of their net asset values[16]. - The financial assets at fair value through profit or loss were primarily listed shares on different stock exchanges[16]. - The net gain on financial assets at fair value through profit or loss for Global X China Cloud Computing ETF was HK$181,503,862, a significant increase from HK$135,402,943 in 2019[35]. - The total comprehensive income for Global X China Biotech ETF was HK$174,321,530 for the year ended March 31, 2020, compared to HK$132,009,464 in the previous year, representing an increase of about 32.1%[35]. - The China Cloud Computing ETF aims to closely correspond to the performance of the Solactive China Cloud Computing Index NTR[55]. - The MSCI China ETF's objective is to provide investment results that closely correspond to the performance of the MSCI China Index[51]. - The Hang Seng High Dividend Yield ETF seeks to match the performance of the Hang Seng High Dividend Yield Index[52]. Management and Fees - Management fees for Global X MSCI China ETF totaled HK$599,491, a reduction from HK$1,131,375 in the previous year, indicating a decrease of approximately 47.0%[35]. - The management fee for the MSCI China ETF was 0.049% of the net asset value for 2020, with a management fee payable of HK$135,992[126]. - The trustee fee for the MSCI China ETF was HK$138,767 for 2020, compared to HK$73,186 in 2019[134]. - The total expenses for the MSCI China ETF included a trustee fee of HK$138,767 and an administration fee of HK$197,055 for the year ended March 31, 2020[134][136]. - For the year ended 31 March 2020, the total administration fee for MSCI China ETF was HK$888,948, a decrease of 32.7% from HK$1,323,514 in 2019[137]. Risk Management - The Sub-Funds limit their exposure to credit risk by transacting with well-established broker-dealers and banks with high credit ratings, ensuring minimal default risk[183]. - The Sub-Funds' liquidity risk is managed by investing in securities expected to be liquidated within one month or less, with daily monitoring of liquidity positions[193]. - The majority of the Sub-Funds' financial assets and liabilities are non-interest-bearing, indicating low exposure to interest rate risk[180]. - The Sub-Funds are subject to a 10% PRC Withholding Income Tax (WIT) on dividend income received from China A-shares and China H-shares[167]. Unit and Shareholder Information - The number of units in issue for Global X MSCI China ETF was 27,400,000, down from 52,800,000 in 2019, a reduction of approximately 48.0%[34]. - As of March 31, 2020, two unitholders held 40% each of the MSCI China ETF's total net assets, indicating a concentration of ownership[196]. - The total number of units for MSCI China ETF decreased from 102,600,000 in 2019 to 52,800,000 in 2020, a reduction of approximately 48.5%[116]. Financial Assets and Liabilities - The financial assets at fair value through profit or loss were HK$137,994,769, with no assets maturing in the 1 to 12 months range[199]. - The total financial liabilities were HK$47,229, with HK$45,857 due within one month[199]. - The carrying value of financial assets not subject to IFRS 9's impairment requirements represents the Sub-Funds' maximum exposure to credit risk, with no separate maximum exposure disclosure provided[188]. - The total financial assets subject to IFRS 9's impairment requirements amounted to HK$16,673,119, an increase of 99.5% from HK$8,385,814 in 2019[185].

Financial Performance - As of September 30, 2019, the total assets for Mirae Asset Horizons MSCI China ETF were HK$1,074,530,338, a decrease from HK$1,762,540,297 as of March 31, 2019[5]. - For the six months ended September 30, 2019, the dividend income for Mirae Asset Horizons MSCI China ETF was HK$27,505,096, down 54.3% from HK$60,114,286 in the same period of 2018[6]. - The net loss on financial assets at fair value through profit or loss for Mirae Asset Horizons MSCI China ETF was HK$142,305,039, compared to a loss of HK$415,667,166 in the previous year[6]. - The profit after tax and total comprehensive income for Mirae Asset Horizons MSCI China ETF was a loss of HK$118,812,708, compared to a loss of HK$366,414,978 in the previous year[6]. - The operating loss for Mirae Asset Horizons MSCI China ETF was HK$116,750,098 for the six months ended September 30, 2019[6]. - For the six months ended 30 September 2019, Mirae Asset Horizons MSCI China ETF reported a loss before tax of HK$116,750,155, an improvement from a loss of HK$361,902,010 in the same period of 2018[9]. - The cash generated from operations for the MSCI China ETF was HK$557,713,637, compared to HK$1,555,439,501 for the same period in 2018, indicating a decrease of approximately 64.1%[9]. - The net cash flows generated from operating activities for the MSCI China ETF were HK$581,361,916, down from HK$1,607,807,771 in the previous year, reflecting a decline of about 63.8%[9]. - The Hang Seng High Dividend Yield ETF experienced a loss before tax of HK$19,861,794, compared to a loss of HK$9,946,423 in the prior year, representing an increase in losses of approximately 99.3%[11]. - The total expenses for Hang Seng High Dividend Yield ETF for the six months ended 30 September 2019 amounted to HK$230,742, an increase of 4.5% from HK$221,827 in the same period of 2018[108]. Asset and Liability Overview - The net assets attributable to unitholders for Mirae Asset Horizons MSCI China ETF decreased to HK$1,056,215,828 from HK$1,755,770,208 at the beginning of the period[7]. - The total liabilities for Mirae Asset Horizons MSCI China ETF were HK$18,314,510, an increase from HK$6,770,089 as of March 31, 2019[5]. - The number of units in issue for Mirae Asset Horizons MSCI China ETF was 34,800,000 as of September 30, 2019, down from 52,800,000[5]. - As of 30 September 2019, the cash and cash equivalents for the MSCI China ETF stood at HK$8,903,127, a decrease from HK$16,157,611 at the beginning of the period[9]. - The total cash and cash equivalents for the Hang Seng High Dividend Yield ETF at the end of the period were HK$561,964, down from HK$2,012,078 at the beginning of the period, indicating a decrease of approximately 72.0%[11]. Investment Portfolio - As of 30 September 2019, Alibaba Group Holding Limited accounted for 13.77% of MSCI China ETF's net asset value, while Tencent Holdings Ltd. accounted for 13.93%[130]. - The investment portfolio includes significant holdings in various sectors, with notable investments in technology and finance[140]. - The fair value of the total investments is aligned with the tracked indices, ensuring a strategic investment approach[136]. - The MSCI China ETF holds a total of HK$1,049,000,000 in listed equities as of September 30, 2019, with a significant allocation to the Industrial and Commercial Bank of China, representing 2.53% of net assets[143]. - The ETF has a diverse portfolio with over 200 listed equities, reflecting a broad exposure to the Chinese market[144]. - The fair value of the holdings in the technology sector, including companies like Meituan Dianping and NetEase, exceeds HK$18 billion, highlighting the sector's importance[144]. - The ETF's allocation to healthcare stocks, such as Jiangsu Hengrui Medicine Co, is approximately HK$1.37 billion, representing a strategic focus on this growing sector[144]. - The fund's exposure to consumer discretionary stocks, including Li Ning Co Ltd, is valued at HK$3.57 billion, indicating a bullish outlook on consumer spending in China[144]. Management and Governance - Management has assessed the Sub-Funds' ability to continue as a going concern and is satisfied that they have the resources to continue in business for the foreseeable future[25]. - The Sub-Funds have adopted IFRS 9 Financial Instruments, impacting the classification and measurement of financial assets and liabilities[27]. - The Manager is identified as the chief operating decision-maker responsible for allocating resources and assessing performance of the operating segments[67]. - Mirae Asset Global Investments (Hong Kong) Limited is the manager of the ETFs[189]. - Cititrust Limited serves as the trustee for the funds[189]. - Ernst & Young is the appointed auditor for the management[189]. - The funds are administered from Three Pacific Place, Hong Kong[189]. - The legal adviser to the manager is Simmons & Simmons[189]. Changes in Holdings - The total closing holdings for the MSCI China ETF as of September 30, 2019, amounted to 5,000,000,000 HKD[169]. - The total closing holdings for the CSI 300 ETF as of September 30, 2019, amounted to 1,123,000 shares after various additions and disposals[179]. - The total closing holdings for Shandong Gold Mining Co Ltd increased to 9,310 shares, reflecting a net addition of 2,660 shares during the period[181]. - The total closing holdings for Zijin Mining Group Co Ltd decreased to 91,997 shares after a disposal of 5,700 shares[181]. - The total holdings for China Railway Group decreased to 3,400 shares, resulting in a closing balance of 55,029 shares[179]. Taxation and Compliance - The Sub-Funds are exempt from Hong Kong profits tax as they are authorized collective investment schemes under the Hong Kong Securities and Futures Ordinance[119]. - The Sub-Funds did not accrue any PRC corporate income tax and VAT provisions for gains made on China A-shares through RQFII quotas and Stock Connect programs[125].